Liver Science Archives - Page 12 of 31 - The MASH Podcast

S4-19.1 – How Did the Patient Advocates Come to Offer Testimonies?

Patient advocates and friends of the podcast Mike Betel (Fatty Liver Alliance), Tony Villiotti (NASHkNOWledge) and Wayne Eskridge (Fatty Liver Foundation) join co-hosts Louise Campbell and Roger Green to share a range of impressions on a public comments session around the draft report released by the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH. This opening conversation reveals how each guest became involved in the process and offers a preview of their reactions to the experience.

May 6, 2023

S2-4 – What Can You Do Today to Prevent and Treat Fatty Liver Disease?

Ken Cusi and Roger Green are joined by Diana Barb and Jay Shubrook in a discussion around effective therapies and strategies for fighting fatty liver disease that are available now. The group discusses frontline screening, medications, bariatric surgery, lifestyle management, practical insights and much more.

May 5, 2023

S4-19 – Patient Advocate Panel Responds to ICER Draft Report on Resmetirom and Obeticholic Acid for NASH

Patient advocates and friends of the podcast Mike Betel (Fatty Liver Alliance), Tony Villiotti (NASHkNOWledge) and Wayne Eskridge (Fatty Liver Foundation) join co-hosts Louise Campbell and Roger Green to share a range of impressions on a public comments session regarding the draft report released by the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH.

May 4, 2023

S4-18.6 – From the Vault: Clinical Care Pathway: What Can Be Done Today?

Last author and leading endocrinology Fatty Liver Opinion Leader Ken Cusi joins co-author Stephen Harrison, Louise Campbell and Roger Green to discuss the recent Clinical Care Pathway published in Gastroenterology. This conversation From the Vault answers the question “What Can Be Done Today?” in terms of screening and patient management without approved drugs.

April 30, 2023

S4-18.5 – Allied Health Professionals and Patient Identification in Endocrinology Clinics

Cyrielle Caussy and the Surfers explore final thoughts on identifying NAFLD/NASH patients earlier on in endocrinology settings and the role of allied health professionals in making this possible. Finally, each panelist is asked what they would do if they had a magic wand to touch one thing in their hospital to make a change.

April 30, 2023

S4-18.4 – Empowering Physicians Through Simple Tools and the Demise of Beethoven

Cyrielle Caussy and the Surfers explore the strength of simple tools that closely link consequence to physicians and push for the identification and risk stratification of respective patient populations. This session also entertains with a fascinating anecdote on the famous composer, Beethoven, and his liver health.

April 30, 2023

S4-18.3 – Positive Engagement with Biofeedback and NAFLD/NASH in Chronic Kidney Patients

Cyrielle Caussy joins the Surfers to talk about how patients can be motivated by biofeedback to improve both liver health and overall condition. Following, the group discusses how specific phenotypes in chronic kidney patients can be targeted for high risk of NAFLD/NASH.

April 29, 2023

S4-18.2 – Risk Stratification and Identification of NAFLD/NASH Patients in the Endocrinology Setting

In continuing conversation around clinical care pathways and the complex of metabolic diseases, SurfingNASH explores the key relationship and interplay between endocrinology and hepatology. This conversation features Cyrielle Caussy alongside Surfers Jörn Schattenberg, Louise Campbell and Roger Green discussing why endocrinology clinics are a critical setting for early identification of patients with NAFLD and NASH.

April 29, 2023

S4-18.1 – Meeting Cyrielle Caussy at the Intersection of Endocrinology and Hepatology

In continuing conversation around clinical care pathways and the complex of metabolic diseases, SurfingNASH explores the key relationship and interplay between endocrinology and hepatology. Jörn Schattenberg, Louise Campbell and Roger Green are joined by Cyrielle Caussy to discuss interprofessional collaboration, education and awareness on Fatty Liver disease and early identification of at-risk populations.

April 29, 2023

S4-18 – Interplay of Endocrinology and Hepatology in Treatment and Knowledge Development

As part of ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to focus on the key relationship and interplay between endocrinology and hepatology. Jörn Schattenberg, Louise Campbell and Roger Green are joined by Cyrielle Caussy to discuss interprofessional collaboration and education for early identification of at-risk populations.

April 26, 2023

Category: Liver Science

All Podcast Categories

S4-19.1 – How Did the Patient Advocates Come to Offer Testimonies?

S2-4 – What Can You Do Today to Prevent and Treat Fatty Liver Disease?

S4-19 – Patient Advocate Panel Responds to ICER Draft Report on Resmetirom and Obeticholic Acid for NASH

S4-18.6 – From the Vault: Clinical Care Pathway: What Can Be Done Today?

S4-18.5 – Allied Health Professionals and Patient Identification in Endocrinology Clinics

S4-18.4 – Empowering Physicians Through Simple Tools and the Demise of Beethoven

S4-18.3 – Positive Engagement with Biofeedback and NAFLD/NASH in Chronic Kidney Patients

S4-18.2 – Risk Stratification and Identification of NAFLD/NASH Patients in the Endocrinology Setting

S4-18.1 – Meeting Cyrielle Caussy at the Intersection of Endocrinology and Hepatology

S4-18 – Interplay of Endocrinology and Hepatology in Treatment and Knowledge Development

Listen Now

Sponsoring Partnerships

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.